SCHALLENBERGER MARK A. (Chief Operating Officer) received a stock award from XTANT MEDICAL HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/17/2023ACC: 0001235802-23-000027
Officer· Chief Operating Officer
Since Feb 2026
+194K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
194K acquired
Non-Derivative Transactions1
Common Stock, $0.000001 par value
Direct
Shares
+89K
Price / share
—
Trade value
—
% of position
New position
2/15/2023
0.00→89K
Total
Net shares
+89K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.000001 par value Direct | 2/15/2023 | A · Award | +89K | — | — | New position | 0.00 | 89K |
| Total | +89K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
105K shares
Shares
+105K
Strike price
0.77
Held after
105K
Exercisable
—
2/15/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock105K shares | 2/15/2023 | A · Award | +105K | 0.77 | — | 105K |